|This article needs additional citations for verification. (March 2011) (Learn how and when to remove this template message)|
|Preferred IUPAC name
|3D model (Jmol)||Interactive image|
|Molar mass||86.136 g/mol|
|Appearance||White crystalline solid|
|Melting point||106 °C (223 °F; 379 K)|
|Boiling point||146 °C (295 °F; 419 K) Sublimates|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|what is ?)(|
Piperazine (//) is an organic compound that consists of a six-membered ring containing two nitrogen atoms at opposite positions in the ring. Piperazine exists as small alkaline deliquescent crystals with a saline taste.
Origin and naming
Piperazines were originally named because of their chemical similarity with piperidine, part of the structure of piperine in the black pepper plant (Piper nigrum). It is important to note, however, that piperazines are not derived from plants in the Piper genus.
Piperazine is freely soluble in water and ethylene glycol, but insoluble in diethyl ether. It is a weak base with two pKbs of 5.35 and 9.73 at 25°C.; the pH of a 10% aqueous solution of piperazine is 10.8-11.8. Piperazine readily absorbs water and carbon dioxide from the air. Although many piperazine derivatives occur naturally, piperazine itself can be synthesized by reacting alcoholic ammonia with 1,2-dichloroethane, by the action of sodium and ethylene glycol on ethylene diamine hydrochloride, or by reduction of pyrazine with sodium in ethanol.
Two common salts in the form of which piperazine is usually prepared for pharmaceutical or veterinary purposes are the citrate, 3C4H10N2.2C6H8O7 (i.e. containing 3 molecules of piperazine to 2 molecules of citric acid), and the adipate, C4H10N2.C6H10O4 (containing 1 molecule each of piperazine and adipic acid).
Piperazine is formed as a co-product in the ammoniation of 1,2-dichloroethane or ethanolamine. These are the only routes to the chemical used commercially. The piperazine is separated from the product stream, which contains ethylenediamine, diethylenetriamine, and other related linear and cyclic chemicals of this type.
As an anti-helmintic
Piperazine was first introduced as an anthelmintic in 1953. A large number of piperazine compounds have anthelmintic action. Their mode of action is generally by paralysing parasites, which allows the host body to easily remove or expel the invading organism. The neuromuscular effects are thought to be caused by blocking acetylcholine at the myoneural junction. This action is mediated by its agonist effects upon the inhibitory GABA (γ-aminobutyric acid) receptor. Its selectivity for helminths is because vertebrates only use GABA in the CNS and the helminths' GABA receptor is a different isoform to the vertebrates' one.
Piperazine hydrate, piperazine adipate and piperazine citrate (used to treat ascariasis and enterobiasis) are the most common anthelmintic piperazine compounds. These drugs are often referred to simply as "piperazine" which may cause confusion between the specific anthelmintic drugs, the entire class of piperazine-containing compounds, and the compound itself.
Piperazines are also used in the manufacture of plastics, resins, pesticides, brake fluid and other industrial materials. Piperazines, especially BZP and TFMPP were extremely common adulterants in the club and rave scene, often being passed off as MDMA, although they do not share many similarities in their effects.
Piperazine is also a fluid used for CO2 and H2S scrubbing in association with methyl diethanolamine (MDEA).
Carbon Capture and Storage
Amine blends that are activated by concentrated piperazine are used extensively in commercial CO2 removal for carbon capture and storage (CCS) because piperazine advantageously allows for protection from significant thermal and oxidative degradation at typical coal flue gas conditions. The thermal degradation rates for methyl diethanolamine (MDEA) and piperazine (PZ) are negligible, and PZ, unlike other metals, protect MDEA from oxidative degradation. This increased stability of the MDEA/PZ solvent blend over MDEA and other amine solvents provides for greater capacity for and requires less work to capture a given amount of CO2.
Piperazine's solubility is low, so it is often used in relatively small amounts to supplement another amine solvent. One or more of piperazine's performance advantages are often compromised in practice due to its low concentration; nonetheless, the CO2 absorption rate, heat of absorption, and solvent capacity are increased through the addition of piperazine to amine gas treating solvents, the most common of which is MDEA due to its unmatched high rate and capacity efficiency. For example, a 5 m PZ/5 m MDEA blend yields an 11% larger difference in CO2 concentration than 8 m PZ between the lean (inlet absorbent) and rich (outlet absorbent) amine solvent streams, or in other words, more CO2 is removed from the sour (flue) gas stream per unit mass of solvent, and an almost 100% larger concentration difference than 7 m MEA. 
Given that typical amine-based absorption processes run at temperatures from 45°C to 55°C, the capabilities of piperazine are well within the bounds of and thus favored for carbon capture. Piperazine can be thermally regenerated through multi-stage flash distillation and other methods after being used in operating temperatures up to 150°C and recycled back into the absorption process, providing for higher overall energy performance in amine gas treating processes.
The advantages to using concentrated piperazine (CPZ) as an additive had been confirmed through, for example, three pilot plants in Australia that are operated by CSIRO. This program was launched to explore remedies to the high costs of post-combustion carbon capture, and the results were positive. Using CPZ, which is more reactive and thermally stable than standard MEA solutions, capital and compression (energy) costs were lowered through size reductions in absorber columns and solvent regeneration at higher temperatures.
The amine groups on piperazine react readily with carbon dioxide to produce PZ carbamate at a low loading (mol CO2/equiv PZ) range and PZ bicarbamate at an operating range of 0.31-0.41 mol CO2/equiv PZ, enhancing the rate of overall CO2 absorbed under operating conditions (refer to Figure 1 below). Due to these reactions, there is limited free piperazine present in the solvent, resulting in its low volatility and rates of precipitation as PZ-6H2O.
Piperazine derivatives as drugs
Many currently notable drugs contain a piperazine ring as part of their molecular structure. Examples include:
- 4-Bromo-2,5-dimethoxy-1-benzylpiperazine (2C-B-BZP)
- 1-Benzylpiperazine (BZP)
- 2,3-Dichlorophenylpiperazine (DCPP)
- 1,4-Dibenzylpiperazine (DBZP)
- 4-Methyl-1-benzylpiperazine (MBZP)
- 3-Chlorophenylpiperazine (mCPP)
- 3,4-Methylenedioxy-1-benzylpiperazine (MDBZP)
- 4-Methoxyphenylpiperazine (MeOPP)
- Methoxypiperamide (MeOP or MEXP)
- 4-Chlorophenylpiperazine (pCPP)
- 4-Fluorophenylpiperazine (pFPP)
- 3-Trifluoromethylphenylpiperazine (TFMPP)
Most of these agents can be classified as either phenylpiperazines, benzylpiperazines, diphenylmethylpiperazines (benzhydrylpiperazines), pyridinylpiperazines, pyrimidinylpiperazines, or tricyclics (with the piperazine ring attached to the heterocyclic moiety via a side chain).
- Merck Index, 11th Edition, 7431
- The Merck index, 10th Ed. (1983), p. 1076, Rahway:Merck & Co.
- Ashford’s Dictionary of Industrial Chemicals, 3rd edition, 7332
- "Modes of action of anthelmintic drugs". The Veterinary Journal. 154(1). 31 July 1997.
|last1=in Authors list (help)
- "Helminths: Intestinal nematode infection: Piperazine". WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition. WHO. 1995. Retrieved 2015-08-29.
- Closmann, Fred; Nguyen, Thu; Rochelle, Gary T. (February 2009). "MDEA/Piperazine as a solvent for CO2 capture". Energy Procedia. 1 (1): 1351–1357. Retrieved 15 April 2016.
- Li, Le; Voice, Alexander K.; Li, Han; Namjoshi, Omkar; Nguyen, Thu; Du, Yang; Rochelle, Gary T. (2013). "Amine blends using concentrated piperazine". Energy Procedia. 37: 353–369. Retrieved 15 April 2016.
- Rochelle, Gary; Chen, Eric; Freeman, Stephanie; Wagener, David V.; Xu, Qing; Voice, Alexander (15 July 2011). "Aqueous piperazine as the new standard for CO2 capture technology". Chemical Engineering Journal. 171 (3): 725–733. Retrieved 15 April 2016.
- Cottrell, Aaron; Cousins, Ashleigh; Huang, Sanger; Dave, Narendra; Do, Thong; Feron, Paul H.M.; McHugh, Stephen; Sinclair, Michael (September 2013). Concentrated Piperazine based Post-Combustion Capture for Australian coal-fired power plants (Report). Australian National Low Emissions Coal Research & Development. p. 9-31. Retrieved 3 May 2016.
|Wikisource has the text of the 1911 Encyclopædia Britannica article Piperazin.|
- "PIPERAZINE CITRATE". Сhemicalland21.com. Retrieved 2015-08-29.